Based in India, ErlySign is a startup.
ErlySign develops a saliva-based, non-invasive diagnostic test for early detection of oral cancer that produces results in about 15 minutes. The company has secured funding and regulatory approvals and is scaling clinical trials and partnerships with oncology centers in India while advancing biomarker R&D for broader multi-cancer detection.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.